Definitive Contract HHSD200201691963C
Award Date 9/9/16
Potential Completion Date 11/14/17
Potential Value $460K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>This is a $546,085 firm fixed-price definitive contract awarded on September 1, 2020 by the Centers for Disease Control and Prevention (CDC), a civilian agency, to Yale University, a private university, for the identification of epidemiologic and microbiome-related risk factors. The contract has an ultimate completion date of February 28, 2022. This contract does not have a set-aside designation. The place of performance is Hamden, CT.</p>
- This is a definitive, firm fixed price contract awarded to Yale University by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The contract, valued at $1,980,573.00, is for the FY22 Broad Agency Announcement (BAA) YALE, with a period of performance through March 18, 2025. The contract is not set-aside. As a private university, Yale University is registered in the System for Award Management (SAM) and provides a range of services including education and research. Through this...
- Yale University was awarded a definitive firm fixed-price contract valued at $414,315 by the Centers for Disease Control and Prevention (CDC) Pittsburgh to assess the contamination and survivability of SARS-CoV-2 on various surfaces and materials. The contract, awarded on September 28, 2020, with an ultimate completion date of September 27, 2022, represents the CDC's effort to understand transmission dynamics of the novel coronavirus during the early phases of the COVID-19 pandemic. The work was...
- This is a $847,345.00 firm fixed price federal contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Yale University, a private non-profit research university, to conduct research on virus genomics and human mobility patterns related to the spread of SARS-CoV-2. The contract has a completion date of September 20, 2022 and was originally awarded on September 22, 2020. As part of this contract, Yale University has issued a subcontract to...
- This is a Firm Fixed Price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Yale University to conduct SARS-CoV-2 sero-surveillance in indigenous casino workers. The contract has a ceiling value of $699,595.00 and a period of performance through April 30, 2022. There was no set-aside used for this award. As a private research university, Yale University has a history of providing research, analysis, and testing services to various federal agencies through...
- This is a $449,417 firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to The Washington University for a study on "Fecal Microbiome Disruptions." The Washington University, a private research university, is serving as the prime contractor on this award. The contract does not appear to have any set-aside designation. The Washington University has extensive experience partnering with federal agencies like the Department of Defense, Department of...
- This is a $368,548 firm-fixed-price definitive contract awarded by the U.S. Department of Health and Human Services Centers for Disease Control and Prevention to the Regents of the University of Michigan to conduct a "Longitudinal Impact Study of Prophylactic Antibiotic Use on the Gut Microbiota". The contract has a completion date of December 29, 2019 and was awarded on September 30, 2018. The University of Michigan is a U.S. state government, educational institution, and...
- The Centers for Disease Control and Prevention awarded a firm fixed price definitive contract valued at four hundred eighty-six thousand eight hundred forty-nine dollars ($486,849) to The Washington University for research on the human gut microbiome's disruption and susceptibility to antibiotics. As the prime contractor, The Washington University will conduct the requested research under this contract to the CDC, which focuses on understanding how changes in gut bacteria may impact individuals'...
- This is a $750,000.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Maryland, College Park (UMD) to support the agency's FY 2020 COVID-19 Broad Agency Announcement (BAA) Topic 1 research efforts. The contract has a period of performance through March 30, 2024 and utilizes cost-reimbursement pricing with no fee. UMD is providing research, analysis, and other professional services related to the COVID-19 pandemic response. This award...
- This is a firm fixed price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Maryland, Baltimore (UMB) on March 31, 2020. The contract is valued at $781,292.00 and has a completion date of June 30, 2024. The contract was not set aside for any socioeconomic program. UMB, a state government-owned educational institution, is providing research and other services to the CDC through this contract. The University System of Maryland is the parent...